CODX vs EFX
Co-Diagnostics, Inc. Common Stock (CODX) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
CODX currently screens at market cap $31.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the CODX and EFX stock pages for the full models.
Not investment advice.